Copyright: ©Author(s) 2026. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution-NonCommercial (CC BY-NC 4.0) license. No commercial re-use. See permissions. Published by Baishideng Publishing Group Inc.
Hearing diabetes in a one-minute electrocardiogram: Why phenotype-stratified machine learning may outperform one-size-fits-all screening
Mehrnaz Azarian, Center for Innovations in Quality, Michael E DeBakey VA Medical Center, Effectiveness and Safety, Houston, TX 77021, United States
Mehrnaz Azarian, Department of Medicine, Baylor College of Medicine, Houston, TX 77030, United States
Author contributions: Azarian M is the single author of this manuscript.
Conflict-of-interest statement: The author declares that there are no conflicts of interest related to this work.
Corresponding author: Mehrnaz Azarian, MD, Post Doctoral Researcher, Postdoc, Center for Innovations in Quality, Michael E DeBakey VA Medical Center, Effectiveness and Safety, 2450 Holcombe Blvd, Suite 01Y, Houston, TX 77021, United States. mehrnaz.azarian@bcm.edu
Received: January 26, 2026
Revised: February 18, 2026
Accepted: April 16, 2026
Published online: July 26, 2026
Processing time: 172 Days and 12.9 Hours
Revised: February 18, 2026
Accepted: April 16, 2026
Published online: July 26, 2026
Processing time: 172 Days and 12.9 Hours
Core Tip
Core Tip: A one-minute, single-lead electrocardiogram (ECG) may enable scalable screening for diabetes mellitus (DM) when paired with machine learning. Karbovskaya et al introduced a phenotype-clustering strategy that explicitly accounts for clinical heterogeneity and cardiovascular comorbidity, revealing that DM-related ECG signatures are most detectable in specific patient subgroups rather than uniformly across populations. By emphasizing interpretable electrophysiologic features and testing model transportability across phenotypes, this work advances a “precision screening” paradigm and provides a practical roadmap for translating ECG-based metabolic risk detection into real-world cardiometabolic workflows.